These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 15627833)

  • 1. Effects of advanced glycation end products on hyaluronan photolysis: a new mechanism of diabetic vitreopathy.
    Katsumura C; Sugiyama T; Nakamura K; Obayashi H; Hasegawa G; Oku H; Ikeda T
    Ophthalmic Res; 2004; 36(6):327-31. PubMed ID: 15627833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy.
    Stitt AW; Moore JE; Sharkey JA; Murphy G; Simpson DA; Bucala R; Vlassara H; Archer DB
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2517-23. PubMed ID: 9856760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased vitreal hyaluronan levels with aging.
    Itakura H; Kishi S; Kotajima N; Murakami M
    Ophthalmologica; 2009; 223(1):32-5. PubMed ID: 18953185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Muller cells.
    Hirata C; Nakano K; Nakamura N; Kitagawa Y; Shigeta H; Hasegawa G; Ogata M; Ikeda T; Sawa H; Nakamura K; Ienaga K; Obayashi H; Kondo M
    Biochem Biophys Res Commun; 1997 Jul; 236(3):712-5. PubMed ID: 9245719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosphingolipid changes induced by advanced glycation end-products.
    Natalizio A; Ruggiero D; Lecomte M; Lagarde M; Wiernsperger N
    Biochem Biophys Res Commun; 2001 Feb; 281(1):78-83. PubMed ID: 11178963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy.
    Kakehashi A; Inoda S; Mameuda C; Kuroki M; Jono T; Nagai R; Horiuchi S; Kawakami M; Kanazawa Y
    Diabetes Res Clin Pract; 2008 Mar; 79(3):438-45. PubMed ID: 18053608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.
    Yamagishi S; Matsui T; Nakamura K; Yoshida T; Takeuchi M; Inoue H; Yoshida Y; Imaizumi T
    Ophthalmic Res; 2007; 39(2):92-7. PubMed ID: 17284935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
    Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H
    J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hyaluronan lyase, hyaluronidase, and chondroitin ABC lyase on mammalian vitreous gel.
    Bishop PN; McLeod D; Reardon A
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2173-8. PubMed ID: 10476780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy.
    Endo M; Yanagisawa K; Tsuchida K; Okamoto T; Matsushita T; Higuchi M; Matsuda A; Takeuchi M; Makita Z; Koike T
    Horm Metab Res; 2001 May; 33(5):317-22. PubMed ID: 11440280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aging of the vitreous body. Role of glycation and free radicals].
    Deguine V; Labat-Robert J; Ferrari P; Pouliquen Y; Menasche M; Robert L
    Pathol Biol (Paris); 1997 Apr; 45(4):321-30. PubMed ID: 9296081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenomedullin and leptin levels in diabetic retinopathy and retinal diseases.
    Er H; Doğanay S; Ozerol E; Yürekli M
    Ophthalmologica; 2005; 219(2):107-11. PubMed ID: 15802936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy.
    Yamagishi S; Takeuchi M; Inagaki Y; Nakamura K; Imaizumi T
    Int J Clin Pharmacol Res; 2003; 23(4):129-34. PubMed ID: 15224502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epigenetic mechanisms of aging: relations between Maillard reactions and radical generation].
    Deguine-Delay V; Menasche M; Schaeverbeke M; Schaeverbeke J; Pouliquen Y; Robert L
    C R Seances Soc Biol Fil; 1997; 191(2):247-52. PubMed ID: 9255351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RAGE axis in early diabetic retinopathy.
    Barile GR; Pachydaki SI; Tari SR; Lee SE; Donmoyer CM; Ma W; Rong LL; Buciarelli LG; Wendt T; Hörig H; Hudson BI; Qu W; Weinberg AD; Yan SF; Schmidt AM
    Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2916-24. PubMed ID: 16043866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidants and an inhibitor of advanced glycation ameliorate death of retinal microvascular cells in diabetic retinopathy.
    Yatoh S; Mizutani M; Yokoo T; Kozawa T; Sone H; Toyoshima H; Suzuki S; Shimano H; Kawakami Y; Okuda Y; Yamada N
    Diabetes Metab Res Rev; 2006; 22(1):38-45. PubMed ID: 15892182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glutamate concentration in diabetic vitreous].
    Asensio Sánchez VM; Corral Azor A; Aguirre Aragón B; De Paz García M
    Arch Soc Esp Oftalmol; 2003 Sep; 78(9):493-7. PubMed ID: 14517736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects.
    Uribarri J; Stirban A; Sander D; Cai W; Negrean M; Buenting CE; Koschinsky T; Vlassara H
    Diabetes Care; 2007 Oct; 30(10):2579-82. PubMed ID: 17496238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
    Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
    Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.